Related Experiment Video
Updated: Apr 23, 2026

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 17, 2013
Clinical evaluation of new heart valve prostheses: update of objective performance criteria
YingXing Wu1, Eric G Butchart2, Jeffrey S Borer3
1Medical Data Research Center, Providence Health and Services, Portland, Oregon.
Abstract:
This article summarizes the long-term clinical results of the Food and Drug Administration-approved heart valves, provides current updates to the objective performance criteria (OPC) used to evaluate new heart valve prostheses, and documents the steps that the International Organization for Standardization Committee used to arrive at the updated OPC. Data were extracted from 19 Food and Drug Administration summaries of safety and effectiveness data reports (31 series) and 56 literature articles (85 series) published from 1999 to 2012. The OPC were calculated for five valve-related complications by valve type (mechanical and bioprosthetic) and valve position (aortic and mitral).
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis IV: Nursing Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation

